Population-based Results of Chemoradiotherapy for Limited Stage Small Cell Lung Cancer in The Netherlands

Outcome data at the population level for LS-SCLC are equivalent to those reported in clinical trials. The increased use of BID schemes since 2011 did not improve survival.